ACLARIS THERAPEUTICS

Aclaris Therapeutics Provides 2023 Outlook

06 يناير 2023 07:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China

29 نوفمبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Key Leadership Transitions

22 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences

10 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

08 نوفمبر 2022 07:00:03 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations

27 سبتمبر 2022 07:00:24 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

30 أغسطس 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

03 أغسطس 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Expands Leadership Team

27 يونيو 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference

01 يونيو 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

16 مايو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update

10 مايو 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium

03 مايو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update

24 فبراير 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the SVB Leerink Virtual 11th Annual Global Healthcare Conference

02 فبراير 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Expands Leadership Team

01 فبراير 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Provides R&D Update

11 يناير 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference

27 ديسمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic Cancer in Science Translational Medicine

03 ديسمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021

18 نوفمبر 2021 16:01:00 بحسب Nasdaq GlobeNewswire